Romano Brothers & Co’s Veracyte VCYT Stock Holding History

Romano Brothers & Co’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-128	Closed	-$3.04K	–	949
2022 Q4	$3.04K	Buy	+128	New	+$2.98K	﹤0.01%	892

Other funds holding VCYT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Romano Brothers & Co's VCYT Position: Q1 2023 in Review

Romano Brothers & Co sold out of Veracyte (VCYT) in Q1 2023, closing a stake of 128 shares — an estimated $3.04K sold.

Romano Brothers & Co first reported a position in VCYT in Q4 2022 and held it in 1 quarter. The position peaked at $3.04K in Q4 2022. 232 funds tracked by Wall St. Rank hold VCYT as of Q1 2023.

Romano Brothers & Co reported no remaining Veracyte position as of Q1 2023 after selling out during the quarter.
Romano Brothers & Co sold 128 Veracyte shares in Q1 2023, an estimated $3.04K.
Romano Brothers & Co first reported a position in Veracyte in Q4 2022 and held it in 1 quarter.
Romano Brothers & Co's Veracyte position peaked at $3.04K in Q4 2022.
232 funds tracked by Wall St. Rank held Veracyte as of Q1 2023.

Based on Romano Brothers & Co's 13F filing for Q1 2023, filed 13 Apr 2023.